This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Classical Article

. 2001 Nov 15;113(22):851-4.

The effect of l-3,4-dihydroxyphenylalanine (= DOPA) on akinesia in parkinsonism. 1961

[Article in English, German]

W Birkmayer, O Hornykiewicz

PMID: 11763859

Classical Article

The effect of l-3,4-dihydroxyphenylalanine (= DOPA) on akinesia in parkinsonism. 1961

[Article in English, German]

W Birkmayer et al. Wien Klin Wochenschr. 2001.

. 2001 Nov 15;113(22):851-4.

Authors

W Birkmayer, O Hornykiewicz

PMID: 11763859

No abstract available

PubMed Disclaimer

Similar articles

L-DOPA.
Hornykiewicz O. Hornykiewicz O. J Parkinsons Dis. 2017;7(s1):S3-S10. doi: 10.3233/JPD-179004. J Parkinsons Dis. 2017. PMID: 28282813 Free PMC article. Review. No abstract available.
The history of dopamine and levodopa in the treatment of Parkinson's disease.
Fahn S. Fahn S. Mov Disord. 2008;23 Suppl 3:S497-508. doi: 10.1002/mds.22028. Mov Disord. 2008. PMID: 18781671 Review.
[L-dopa: a fascinating history].
García de Yébenes J, García Ruiz P. García de Yébenes J, et al. Neurologia. 1998;13 Suppl 1:36-40. Neurologia. 1998. PMID: 9859684 Spanish. No abstract available.
[Short history of L-Dopa].
García Ruiz PJ, Meseguer E. García Ruiz PJ, et al. Neurologia. 2002 Apr;17(4):214-7. Neurologia. 2002. PMID: 11940409 Spanish.
Levodopa: 50 years of a revolutionary drug for Parkinson disease.
Fahn S, Poewe W. Fahn S, et al. Mov Disord. 2015 Jan;30(1):1-3. doi: 10.1002/mds.26122. Epub 2014 Dec 8. Mov Disord. 2015. PMID: 25488146 No abstract available.

See all similar articles

Cited by

Professor Oleh Hornykiewicz, MD (1926-2020): Remembering the Father of the Modern Treatment of Parkinson's Disease and the Man.
Rajput AH, Kish SJ. Rajput AH, et al. Mov Disord. 2020 Nov;35(11):1916-1921. doi: 10.1002/mds.28317. Epub 2020 Sep 28. Mov Disord. 2020. PMID: 32985723 Free PMC article. No abstract available.
Bivalent dopamine agonists with co-operative binding and functional activities at dopamine D2 receptors, modulate aggregation and toxicity of alpha synuclein protein.
Dinda B, Das B, Biswas S, Sharma H, Armstrong C, Yedlapudi D, Antonio T, Reith M, Dutta AK. Dinda B, et al. Bioorg Med Chem. 2023 Jan 15;78:117131. doi: 10.1016/j.bmc.2022.117131. Epub 2022 Dec 16. Bioorg Med Chem. 2023. PMID: 36571976 Free PMC article.
The Human Experience with Intravenous Levodopa.
Siddiqi SH, Abraham NK, Geiger CL, Karimi M, Perlmutter JS, Black KJ. Siddiqi SH, et al. Front Pharmacol. 2016 Jan 6;6:307. doi: 10.3389/fphar.2015.00307. eCollection 2015. Front Pharmacol. 2016. PMID: 26779024 Free PMC article. Review.
PET Molecular Imaging Research of Levodopa-Induced Dyskinesias in Parkinson's Disease.
Pagano G, Yousaf T, Politis M. Pagano G, et al. Curr Neurol Neurosci Rep. 2017 Oct 3;17(11):90. doi: 10.1007/s11910-017-0794-2. Curr Neurol Neurosci Rep. 2017. PMID: 28975571 Free PMC article. Review.
From the tyrosine hydroxylase hypothesis of Parkinson's disease to modern strategies: a short historical overview.
Rausch WD, Wang F, Radad K. Rausch WD, et al. J Neural Transm (Vienna). 2022 Jun;129(5-6):487-495. doi: 10.1007/s00702-022-02488-3. Epub 2022 Apr 23. J Neural Transm (Vienna). 2022. PMID: 35460433 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

Personal name as subject

Actions
- Search in PubMed
- Add to Search
Actions
- Search in PubMed
- Add to Search

LinkOut - more resources

Medical
- MedlinePlus Health Information